The PRAMEF18 Polyclonal Antibody (PACO62343) is a valuable tool for researchers studying PRAMEF18, a protein involved in cancer progression and metastasis. This antibody, produced using rabbit immunization methods, exhibits high specificity for human samples and is ideal for Western blot applications. By binding to the PRAMEF18 protein, this antibody allows for precise detection and analysis in various cell types, offering valuable insights for studies in oncology and tumor biology.PRAMEF18, a member of the PRAME family of proteins, has been implicated in promoting tumor growth and metastasis in various cancer types.
Understanding the role of PRAMEF18 in cancer development is crucial for identifying potential therapeutic targets and improving treatment strategies. The PRAMEF18 Polyclonal Antibody provides researchers with a reliable tool for investigating the function and expression of PRAMEF18, contributing to advancements in cancer research and drug discovery efforts.
Western Blot. Positive WB detected in: HepG2 whole cell lysate, Hela whole cell lysate, MCF-7 whole cell lysate. All lanes: PRAMEF18 antibody at 1:2000. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 56 kDa. Observed band size: 56 kDa.
IHC image of PACO62343 diluted at 1:400 and staining in paraffin-embedded human colon cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Synonyms:
PRAME family member 18, PRAMEF18
UniProt Protein Function:
PRAMEF18: Belongs to the PRAME family.Chromosomal Location of Human Ortholog: 1p36.21
